“All in-vitro formulation development work needs to be confirmed with in vivo studies” states a thought provoking article published this week.

‍

‍

With both services in our portfolio, and over 20 years in the pharma industry we couldn’t agree more!

Writing in the European Pharmaceutical Manufacturer magazine this week, William Wei Lim Chin does a great job at explaining some of the benefits of spray drying and why it should be in every formulator’s toolkit.

Visit our Formulations page to read more about our own toolkit, and let us know if you have any questions or would like to discuss something further.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

ALL POSTS